Macquarie Value Fund's Q3 2025 Performance Analysis

This report provides a detailed overview of the Macquarie Value Fund's performance during the third quarter of 2025, identifying the major factors that influenced its returns. It delves into specific corporate events and market dynamics that led to both gains and losses within the fund's portfolio, offering insights into its investment approach.

Navigating Market Currents: A Deep Dive into Portfolio Dynamics

Unpacking Detractors: Kenvue's Market Challenges

Kenvue Inc., recognized for its consumer health product portfolio including Tylenol, experienced a significant downturn in the market. The fund's assessment indicates that the 21% share price drop was disproportionate to the actual risks involved, particularly regarding legal claims where Tylenol's exposure to pregnant users is less than 1%.

Fidelity National Information Services: Overcoming Short-Term Obstacles

Fidelity National Information Services Inc., a prominent provider of information technology services, was another major detractor. Despite facing immediate operational challenges and slightly conservative financial projections, the fund maintains that FIS's intrinsic value is underestimated. These issues are seen as temporary, coinciding with the company's strategic shift in banking technology.

Alphabet Inc.'s Ascendance: Driving Portfolio Gains

Alphabet Inc., the conglomerate behind Google's search engine and various technology platforms like Google Cloud, Waymo, and YouTube, emerged as a top performer. Its strong second-quarter financial results, coupled with a favorable resolution in an antitrust case, significantly boosted the fund's returns.

Electronic Arts' Triumph: A Strategic Acquisition's Impact

Video game giant Electronic Arts Inc. also made a substantial positive contribution to the portfolio. A significant buyout offer, valued at $55 billion and representing a 25% premium, led to a surge in its stock, further enhancing the fund's overall performance.